SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001396814-19-000029
Filing Date
2019-11-08
Accepted
2019-11-07 18:12:43
Documents
91
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q - PCRX - 9.30.2019 pcrx-9302019x10xq.htm   iXBRL 10-Q 1849733
2 EXHIBIT 31.1 pcrx-9302019xex311.htm EX-31.1 14825
3 EXHIBIT 31.2 pcrx-9302019xex312.htm EX-31.2 14842
4 EXHIBIT 32.1 pcrx-9302019xex321.htm EX-32.1 9148
10 pacirabiosciencesa05.jpg GRAPHIC 27796
  Complete submission text file 0001396814-19-000029.txt   9272608

Data Files

Seq Description Document Type Size
5 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT pcrx-20190930.xsd EX-101.SCH 63534
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT pcrx-20190930_cal.xml EX-101.CAL 99601
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT pcrx-20190930_def.xml EX-101.DEF 381942
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT pcrx-20190930_lab.xml EX-101.LAB 886526
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT pcrx-20190930_pre.xml EX-101.PRE 545177
84 EXTRACTED XBRL INSTANCE DOCUMENT pcrx-9302019x10xq_htm.xml XML 1600846
Mailing Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054
Business Address 5 SYLVAN WAY SUITE 300 PARSIPPANY NJ 07054 973-254-3560
Pacira BioSciences, Inc. (Filer) CIK: 0001396814 (see all company filings)

IRS No.: 510619477 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35060 | Film No.: 191201614
SIC: 2834 Pharmaceutical Preparations